Herbert Duvivier, M.D.
NPI 1710982731ActiveIndividual· Internal Medicine, Hematology & Oncology· Cheektowaga, NY
Internal Medicine, Hematology & Oncology (M.D.) in Cheektowaga, New York, trained at Tufts University School of Medicine (class of 1988). Their prescriptions cost Medicare Part D more than their services did: $4,585,844 for 1,753 claims, against $60,973 paid for services in 2024. Janssen Biotech, Inc. was the largest of 35 companies reporting payments in 2025, $3,549 in all, mostly food and beverage.
Overview
| NPI | 1710982731 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Jun 16, 2005 |
| Last updated in NPPES | Apr 25, 2025 |
| Certified by provider | Apr 25, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Hematology & Oncology Primary | 207RH0003X | 277161 | NY |
| Internal Medicine, Hematology & Oncology | 207RH0003X | 0101281298 | VA |
| Internal Medicine, Hematology & Oncology | 207RH0003X | 75658 | MN |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Medical Oncology (GA); Practitioner - Medical Oncology (MN); Practitioner - Medical Oncology (NY); Practitioner - Hematology/Oncology (VA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 600 |
|---|---|
| Services billed | 1,092 across 18 procedure codes |
| Paid by Medicare | $60,973 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,753 · 2,531 30-day fills |
|---|---|
| Patients | 481 |
| Total drug cost | $4,585,844 |
| Generic share | 81% of claims |
Education and affiliations
| Medical school | Tufts University School of Medicine |
|---|---|
| Graduation year | 1988 |
| Medicare specialty | Medical Oncology |
| Secondary specialties | Hematology |
Medical group
- Sisters of Charity Hospital of Buffalo New YorkBuffalo, NY · 164 clinicians
Hospital affiliations
- Kenmore Mercy HospitalKenmore, NY
- Mercy Hospital of BuffaloBuffalo, NY
- Sisters of Charity HospitalBuffalo, NY
Industry payments (Open Payments)
- 2025$3,549 · 128 payments from 35 companies
- 2024$617.38 · 6 payments from 6 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Janssen Biotech, Inc. | $631.28 | 20 |
| Pfizer Inc. | $288.67 | 11 |
| Astrazeneca Pharmaceuticals LP | $284.15 | 8 |
| Regeneron Healthcare Solutions, Inc. | $222.63 | 10 |
| E.R. Squibb & Sons, L.L.C. | $176.83 | 4 |
What the 2025 payments were for
- Food and Beverage$3,153 · 124 payments
- Education$395.92 · 4 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Hematology & Oncology providers in Cheektowaga
- 1699783324
All Internal Medicine, Hematology & Oncology providers in New York →